The Art of Prognostication in Advanced Cancer: Missing the Big Picture

Special Article – Palliative Care

J Fam Med. 2016; 3(1): 1050.

The Art of Prognostication in Advanced Cancer: Missing the Big Picture

Anwar S1 and Case A2*

1Hospice and Palliative Care Fellow, Department of Medicine, State University of New York at Buffalo, USA

2Palliative Medicine Director VA Western New York Healthcare System, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Program Director Palliative Medicine Fellowship Buffalo, NY, USA

*Corresponding author: Amy Case, Palliative Medicine Director VA Western New York Healthcare System, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Program Director Palliative Medicine Fellowship Buffalo, NY, USA

Received: December 30, 2015; Accepted: February 18, 2016; Published: February 22, 2016

Abstract

Prognostication is defined as “a statement about what is going to happen in the future.” In the medical arena it pertains to predicting the course and survival of a patient with certain disease processes. It is both a science and an art. Although it is recognized that no physician can ever certainly predict what the future holds, a reasonable estimation of the course ahead can certainly be ascertained and communicated to their patients. Unfortunately, prognostication, especially in advanced cancer, is fraught with many difficulties including not only omission of such discussions, but also inaccurate estimations. Using a case of a patient with metastatic lung cancer whose likelihood of survival was grossly misjudged, we outline how to approach prognostication in advanced cancer.

Keywords:Prognosis; Advanced cancer; Performance status; Metastatic lung cancer; Survival; Palliative care

Case Presentation

Mr. Z was a 69 year old caucasian male who had presented to the emergency department for community acquired pneumonia that had failed outpatient antibiotic therapy. He complained of ongoing cough, production of thick phlegm, low grade fevers and severe back and right hip pain since the last 2 weeks. He also stated during the past few months his desire to eat had decreased, he had lost 20 pounds and that he felt tired, short of breath on exertion and was spending more of his time in bed. Prior to this he was a healthy male with history of hypertension and diabetes mellitus. He was retired, had previously worked as a building contractor and served in the Vietnam War with documented exposure to Agent Orange. Although he no longer smoked, he had a history of 30 pack-years. On examination, he had rhonchi in the right lower lobe of his lung, tenderness of upper thoracic area of back and limited range of motion of his right hip. He was noted to have a white blood cell count of 17 K/mm3 (normal range 4.4- 10.7 K/mm3), albumin of 2.8 g/dL (normal range 3.4- 4.5 g/dL) and corrected calcium of 12.3 mg/dL (normal range 8.4- 9.8 mg/dL). Computed Tomography (CT) of the thorax was performed which showed a new large right upper lobe mass occluding the bronchus and extending into the mediastinum. Post-obstructive pneumonia was noted with mediastinal adenopathy. Upon further imaging the patient was found to have metastatic bone destruction of his thoracic vertebrae and right femur.

He was admitted to the acute medicine service and was given antibiotics, intravenous fluids, a bisphosphonate and opioids. Bronchoscopy was performed and the biopsy revealed invasive nonsmall cell carcinoma. The oncology service was called in to talk to the patient and family about chemotherapeutic options. During the meeting treatment with carboplatin and paclitaxel was presented, along with the possibility of radiation and immunotherapy with the novel agent nivolumab should he progress on standard treatment, based on which he was offered a prognosis of up to three years.

The palliative care team was called for the discussion of advance directives. They reviewed the case and collaborated with the medicine and oncology service, inviting the services to their meeting with the patient as they disagreed with the survival time that had been communicated. The patient was receptive to talking about his disease, having prognosis conveyed and discussing goals of care. Based on priordiscussions with healthcare providers, the patient and family had optimistic expectations. Given his advanced metastatic non-small cell lung cancer with bone involvement, deteriorating functional status, dyspnea, post-obstructive pneumonia, hypoalbuminemia and hypercalcemia, the patient and family were told by the palliative care team that his life expectancy was likely in the realm of weeks to three months and after exploring his goals, recommended hospice care. The patient had difficulty accepting this and expressed the desire for aggressive chemotherapy with no limitations of care.

Over the next few days he became hypoxic, increasingly short of breath, delirious and repeat CT revealed bilateral pulmonary embolisms. He was started on anticoagulation and haloperidol. His hypercalcemia did not respond to treatment. The palliative care team now revisited prognosis with the patient and his family. Although he was no longer cognitively intact, the family was told that his passing away seemed more imminent, as in days to weeks. They were saddened but appreciated the honest disclosure. The patient’s respiratory status improved but his delirium did not reverse and he went on to receive “palliative” chemotherapy per oncology who offered this to honor the patient’s wishes. The subsequent day he deteriorated further and imaging showed his right lung had collapsed due to tumor progression. Another family meeting was held at which point in time the family decided they wanted the patient to be comfortable and not undergo intubation or pursue other treatments. He was brought to the palliative care inpatient unit where he was given oxygen, opioids around the clock for pain and relief of dyspnea, with breakthrough medication and treatment for his delirium. He passed away peacefully in two days and the family went on to raise funds for supporting palliative care at the hospital.

The patient’s actual survival from time of diagnosis of cancer to death was twenty-seven days. The clinician calculation of his inaccurate prognosis in the realm of three years led to his decision for harmful treatments near the end of life, created mistrust of the palliative care team and generated emotional and psychological turmoil for the patient and the family due to drastically conflicting estimations of survival.

Introduction

Prognostication is one of the core skills in medicine [1]. When healthcare providers estimate survival, they must face some of the most serious, emotional and meaningful aspects of their careers [2]. Unfortunately, there is often an emphasis on diagnosis, staging and therapeutics in cancer rather than predicting and conveying prognosis [3]. As medicine leads physicians further away from attaining this skill, they lack the necessary confidence of ascertaining the disease course and likelihood of survival. As an example, amongst a cohort of 697 internists; 89% believed they should avoid being too specific, 80% believed patients expected too much certainty, 60% found making a prognosis stressful and 58% termed it difficult, 56% felt they had inadequate training in prognostication, 50% believed if they were to make an error, patients would lose confidence in them and 43% preferred to wait to be asked by a patient before offering predictions [4]. A systematic review was conducted of 46 studies relating to discussing prognosis with patients with progressive, advanced life-limiting illnesses. Results showed that although the majority of physicians believed that patients and caregivers should be told the truth about the prognosis, in practice, many withheld these discussions. Reasons included perceived lack of training, stress, limited time, fear of a negative impact on the patient, uncertainty about prognostication, requests from caregivers to withhold information and a feeling of hopelessness regarding the unavailability of further curative treatment [5].

On the other hand, majority of patients and families want information regarding the illness, possible future symptoms and their management, and expected survival [6, 7], especially when dealing with cancer [8]. Patients report that they want to have time to express their wishes, to appoint healthcare proxies, to put their financial affairs in order and to make their funeral preparations [9]. Contrary to physician worries [10], prognostic information itself has not been found to contribute towards depression in patients with advanced cancer [11]. Also, when relaying prognostic information, patients with incurable cancer characterized doctor’s behaviors such as appearing to be nervous or uncomfortable, or using euphemisms, as not facilitating hope [12].

Communication of prognosis is essential because it may help facilitate discussion of advance directives which in itself allows patients to avoid potentially harmful and inappropriate cancer therapies towards the end of life [13-15]. Accurate prognostication also results in a higher likelihood of the focus towards aggressive symptom management [16] emphasis on better quality of life and expedited referrals to hospice services [17].

Unfortunately even when physicians do convey prognosis, they are likely to be grossly inaccurate [18] and overoptimistic [19]. Physician approximation of survival is commonly overestimated by a factor of three to five [20]. The recognition of this phenomenon and the progress of palliative medicine have served to startshifting focus towards better training in prognostication.

Formulating a prognosis in advanced cancer

Primarily, it should be recognized that estimation of life expectancy in advanced cancer patients is feasible and facilitated by a number of tools the physician has at their disposal, such as the presence of certain signs and symptoms, laboratory examinations, and prognostic scores [21,22]. While cancer patients are commonly staged by the size of their tumor, how sick they are from the tumor and other medical conditions should not be ignored [23].

Understanding the disease trajectory of cancer: Patients with cancer experience a sharp decline in functional status [24] and quality of life [25] in the last months of life, which can occasionally be blunted by treatment (Figure 1), whereas other diseases tend to have a more gradual decline. Recognizing illness trajectories improves our understanding of the patient and families’ needs [26]. Identifying where the patient lies in the course of disease is important because at earlier stages prognostication is typically based on tumor stage [3,27], whereas this is not the case in advanced disease.